115 related articles for article (PubMed ID: 31594785)
1. Atypical neutrophilic panniculitis as presentation of BCR-ABL1-negative chronic myeloid leukaemia.
Fraticelli P; Benfaremo D; Cardinali M; Gabrielli A
BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31594785
[TBL] [Abstract][Full Text] [Related]
2. Chronic myeloid leukemia-leukemia cutis mimicking a neutrophilic panniculitis-like leukemia cutis: Report of a rare case.
Zelman B; Bode-Omoleye O; Muhlbauer A; Agidi A; Mafee M; Velankar M; Mirza K; Speiser J; Mudaliar K
J Cutan Pathol; 2021 Oct; 48(10):1277-1281. PubMed ID: 33891722
[TBL] [Abstract][Full Text] [Related]
3. Ponatinib-induced neutrophilic panniculitis.
Zhang M; Hassan KM; Musiek A; Rosman IS
J Cutan Pathol; 2014 Jul; 41(7):597-601. PubMed ID: 24602068
[TBL] [Abstract][Full Text] [Related]
4. [Recurrent neutrophilic panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib mesilate and dasatinib].
de Masson A; Bouvresse S; Clérici T; Mahé E; Saïag P
Ann Dermatol Venereol; 2011 Feb; 138(2):135-9. PubMed ID: 21333826
[TBL] [Abstract][Full Text] [Related]
5. Lobular neutrophilic panniculitis associated with DNA methyltransferase inhibitors in the treatment of myeloid disease.
Coleman E; Panse G; Cowper S; Prebet T; Gore S; Leventhal J
J Cutan Pathol; 2019 Dec; 46(12):930-934. PubMed ID: 31254406
[TBL] [Abstract][Full Text] [Related]
6. Co-occurrence of BCR-ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia.
da Costa VEF; de Oliveira RD; Traina F; Chahud F; Palma LC; de Figueiredo-Pontes LL
Br J Haematol; 2020 Feb; 188(3):e21-e23. PubMed ID: 31681999
[No Abstract] [Full Text] [Related]
7. Novel BCR-ABL1 fusion identified by targeted next-generation sequencing in a patient with an atypical myeloproliferative neoplasm.
Frederick L; Beardell F; Viswanatha DS
Hum Pathol; 2014 Aug; 45(8):1784-9. PubMed ID: 24927924
[TBL] [Abstract][Full Text] [Related]
8. From the Deep: Overlap of Neutrophilic Dermatoses Disorders Associated With Acute Myeloid Leukemia.
Martins M; Barbosa J; Eusébio SP; Prayce R; Pires P
Cureus; 2023 Jan; 15(1):e33456. PubMed ID: 36751214
[TBL] [Abstract][Full Text] [Related]
9. Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein.
Brown S; Hutchinson CV; Aspinall-O'Dea M; Whetton AD; Johnson SM; Rees-Unwin K; Burthem J
Eur J Haematol; 2014 Aug; 93(2):96-102. PubMed ID: 24617663
[TBL] [Abstract][Full Text] [Related]
10. [BCR-ABL1-positive chronic myeloid leukemia emerging in a patient with secondary myelofibrosis harboring the JAK2-V617F mutation].
Amemiya A; Ito Y; Ishibashi Y; Saito Y; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Tanaka Y; Fujimoto H; Okabe S; Gotoh M; Tauchi T; Ohyashiki K
Rinsho Ketsueki; 2017; 58(4):298-302. PubMed ID: 28484156
[TBL] [Abstract][Full Text] [Related]
11. Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors.
Pietarinen PO; Eide CA; Ayuda-Durán P; Potdar S; Kuusanmäki H; Andersson EI; Mpindi JP; Pemovska T; Kontro M; Heckman CA; Kallioniemi O; Wennerberg K; Hjorth-Hansen H; Druker BJ; Enserink JM; Tyner JW; Mustjoki S; Porkka K
Oncotarget; 2017 Apr; 8(14):22606-22615. PubMed ID: 28186983
[TBL] [Abstract][Full Text] [Related]
12. Expression of BCR-ABL1 oncogene relative to ABL1 gene changes overtime in chronic myeloid leukemia.
Gupta M; Milani L; Hermansson M; Simonsson B; Markevärn B; Syvänen AC; Barbany G
Biochem Biophys Res Commun; 2008 Feb; 366(3):848-51. PubMed ID: 18082628
[TBL] [Abstract][Full Text] [Related]
13. Chronic myeloid leukemia presenting with absence of basophils and marked dyspoiesis.
Anand M; Kumar R; Kumar L; Barge S; Singh S
Indian J Cancer; 2003; 40(4):144-7. PubMed ID: 14716111
[TBL] [Abstract][Full Text] [Related]
14. [Two cases of subcutaneous panniculitis-like T-cell lymphoma (CD4- CD8+ CD56-)].
Springinsfeld G; Guillaume JC; Boeckler P; Tortel MC; Cribier B
Ann Dermatol Venereol; 2009 Mar; 136(3):264-8. PubMed ID: 19328310
[TBL] [Abstract][Full Text] [Related]
15. Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells.
Topaly J; Zeller WJ; Fruehauf S
Leukemia; 2001 Mar; 15(3):342-7. PubMed ID: 11237055
[TBL] [Abstract][Full Text] [Related]
16. Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network.
Schäfer V; White HE; Gerrard G; Möbius S; Saussele S; Franke GN; Mahon FX; Talmaci R; Colomer D; Soverini S; Machova Polakova K; Cross NCP; Hochhaus A; Ernst T
J Cancer Res Clin Oncol; 2021 Oct; 147(10):3081-3089. PubMed ID: 33677711
[TBL] [Abstract][Full Text] [Related]
17. Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations.
Turakhia SK; Murugesan G; Cotta CV; Theil KS
J Clin Pathol; 2016 Aug; 69(8):713-9. PubMed ID: 26754830
[TBL] [Abstract][Full Text] [Related]
18. Alpha-1 antitrypsin deficiency panniculitis: clinical and pathologic characteristics of 10 cases.
Johnson EF; Tolkachjov SN; Gibson LE
Int J Dermatol; 2018 Aug; 57(8):952-958. PubMed ID: 29707779
[TBL] [Abstract][Full Text] [Related]
19. Very late relapse with rapid BCR-ABL1 elevation after more than seven years of treatment-free remission with undetectable molecular residual disease in chronic myeloid leukaemia.
Katagiri S; Gotoh A; Ohyashiki K
Br J Haematol; 2020 Jan; 188(2):332-334. PubMed ID: 31702048
[No Abstract] [Full Text] [Related]
20. Unusual case of subcutaneous panniculitis-like T-cell lymphoma.
Wells J; Kosky CA; Scolyer RA; Lee S; Bye PT; Young GA; Davies L
Australas J Dermatol; 2004 May; 45(2):114-8. PubMed ID: 15068459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
